Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
37 studies found for:    Open Studies | "Acromegaly"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Lanreotide Levels in Acromegaly
Condition: Acromegaly
Intervention: Other: Blood draw
2 Recruiting The Treatment and Natural History of Acromegaly
Conditions: Acromegaly;   Pituitary Neoplasm
Intervention:
3 Recruiting Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?
Condition: Acromegaly
Intervention:
4 Recruiting A Prospective Study of Outcome After Therapy for Acromegaly
Condition: Acromegaly
Interventions: Procedure: Surgery for acromegaly;   Drug: Medications for acromegaly
5 Unknown  Ultrasound Guided Sandostatin LAR Injection in Acromegaly
Condition: Acromegaly
Intervention: Drug: Sandostatin LAR
6 Recruiting Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues
Condition: Acromegaly
Intervention: Drug: Pasireotide LAR
7 Recruiting Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly
Condition: Acromegaly
Interventions: Drug: Octreotide capsules;   Drug: Injectable Somatostatin Analogs (octreotide or lanreotide);   Drug: Cabergoline
8 Recruiting Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly
Conditions: Cushing's Disease,;   Acromegaly
Interventions: Drug: Pasireotide s.c.;   Drug: Sitagliptin;   Drug: Liraglutide;   Drug: Insulin;   Drug: Pasireotide LAR;   Drug: Metformin
9 Unknown  A Study Examining the Peri- and Post-operative Dynamics of the Growth Hormone (GH) - IGF-1 Axis in Subjects With Acromegaly During the First Year After Surgical Resection
Condition: Acromegaly
Intervention: Other: OGTT
10 Unknown  Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
Conditions: Acromegaly;   Heart Failure;   Hypertrophy, Left Ventricular
Intervention: Drug: pegvisomant
11 Not yet recruiting Endocrine Cardiomyopathy: Response to Cyclic GMP PDE5 Inhibitors in Acromegaly Cardiomyopathy
Condition: Acromegaly Cardiomyopathy
Intervention: Drug: Tadalafil
12 Recruiting Acromegaly & Sleep Apnoea
Condition: Acromegaly
Intervention:
13 Recruiting Late Effects of Radiosurgery on Acromegaly Study
Condition: Acromegaly
Intervention: Device: Gamma Knife radiosurgery
14 Recruiting Validation Study of the SAGIT® Instrument in Acromegaly
Condition: Acromegaly
Intervention:
15 Unknown  Prospective Study on Changes in Acromegaly
Condition: Acromegaly
Intervention:
16 Recruiting IGF-I and Free Fatty Acids Isn Glucose Metabolism in Acromegaly
Condition: Acromegaly
Intervention:
17 Recruiting Assessment of Airway in Patients With Acromegaly for Predicting Successful Tracheal Intubation
Condition: Acromegaly
Intervention: Device: Fiberoptic
18 Unknown  Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations in Acromegaly
Condition: Acromegaly
Intervention:
19 Recruiting Assessment of Changes in Metabolic Activity in Liver & Skeletal Muscle in Patients Suffering From Acromegaly
Condition: Acromegaly
Interventions: Other: 1H/31P Magnetic Resonance Spectroscopy;   Other: oral glucose tolerance testing;   Other: Thyroid sonography
20 Recruiting Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly
Condition: Acromegaly
Intervention: Drug: Lanreotide PRF

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Indicates status has not been verified in more than two years